Skip to content
GenoLensGenoLens

PI4KA

Chr 22q11.21

phosphatidylinositol 4-kinase alpha

Aliases:
PI4K-ALPHA, pi4K230
MANE:
ENST00000255882.11

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Cerebellar hypoplasia

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited white matter disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Malformations of cortical development

    BIALLELIC, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    BIALLELIC, autosomal or pseudoautosomal

+5 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis

    0.75
  • spastic paraplegia 84, autosomal recessive

    0.69
  • multiple intestinal atresia

    0.59
  • neurodegenerative disease

    0.49
  • heparin cofactor 2 deficiency

    0.48
  • CEDNIK syndrome

    0.47
  • PI4KA-related disorder

    0.47
  • gastrointestinal defect and immunodeficiency syndrome

    0.37
  • pleural mesothelioma

    0.37
  • bilateral perisylvian polymicrogyria

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Phosphatidylinositol 4-kinase alpha

Acts on phosphatidylinositol (PtdIns) in the first committed step in the production of the second messenger inositol-1,4,5,-trisphosphate

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.